Richard B. Rothman
Richard B. Rothman is a pharmacologist who received his MD and Ph.D. degrees in pharmacology from the University of Virginia in 1982. Currently he is a senior investigator in the clinical pharmacology section of the National Institute of Drug Abuse's Intramural Research Program. In addition he is a board certified psychiatrist and medical director of the BeLite Medical Centers. His expertise is in studying the opioid system and the monoamine transporters as well as drugs acting on them, such as monoamine releasing agents. Provided by Wikipedia
Showing 1 - 5 results of 5 for search 'Richard Rothman', query time: 0.22s
Refine Results
-
1
-
2
-
3
Author Correction: 2019–2020 H1N1 clade A5a.1 viruses have better in vitro fitness compared with the co-circulating A5a.2 clade by Nicholas J. Swanson, Paula Marinho, Amanda Dziedzic, Anne Jedlicka, Hsuan Liu, Katherine Fenstermacher, Richard Rothman, Andrew Pekosz
Published 2023-10-01
Article -
4
Developing and validating clinical features-based machine learning algorithms to predict influenza infection in influenza-like illness patients by Shang-Kai Hung, Chin-Chieh Wu, Avichandra Singh, Jin-Hua Li, Christian Lee, Eric H. Chou, Andrew Pekosz, Richard Rothman, Kuan-Fu Chen
Published 2023-10-01
Article -
5
The Clinical Review Committee: Impact of the Development of In Vitro Diagnostic Tests for SARS-CoV-2 Within RADx Tech by Matthew Robinson, Charlotte Gaydos, Barbara Van Der Pol, Sally McFall, Yu-Hsiang Hsieh, William Clarke, Robert L. Murphy, Lea E. Widdice, Lisa R. Hirschhorn, Richard Rothman, Chad Achenbach, Claudia Hawkins, Adam Samuta, Laura Gibson, David McManus, Yukari C. Manabe
Published 2021-01-01
Article